Chikungunya Cases Rise in the UK Amid Vaccine Safety Concerns
The number of chikungunya cases in the UK has surged by 170%, with 73 reported cases in 2025 compared to […]
Browsing category
The number of chikungunya cases in the UK has surged by 170%, with 73 reported cases in 2025 compared to […]
As a pharmacist, I see firsthand how patients often struggle to fill their prescriptions. Despite heavy advertising from drug companies, […]
Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps and abscesses, often in areas like the armpits […]
The U.S. Food and Drug Administration (FDA) has appointed Dr. George Tidmarsh as the new director of its Center for […]
Artificial intelligence (AI) is changing how healthcare and drug companies use real-world patient data. But simply using AI isn’t enough—it […]
Bristol Myers Squibb has named Dr. Cristian Massacesi as its new Executive Vice President and Chief Medical Officer, overseeing all […]
A new report predicts that the market for hidradenitis suppurativa (HS) treatments will grow significantly over the next decade, from […]
European drug regulators have recommended rejecting Elevidys, a gene therapy for Duchenne muscular dystrophy (DMD), in a setback for its […]
The pharmaceutical industry is highly competitive, which has led to a big increase in healthcare advertising, with spending expected to […]
Astellas and Apellis are competing for market share in the U.S. for their geographic atrophy (GA) treatments, Izervay and Syfovre. […]